Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors

Neuropharmacology

Volumn 55, Issue 4, 2008, Pages 537-545

  Palazzo, Enza ^a,b   Fu, Yu ^a   Ji, Guangchen ^a   Maione, Sabatino ^b   Neugebauer, Volker ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Amygdala; Anxiety; Arthritis; mGluR; Microdialysis; Pain; Vocalization

Indexed keywords

3,4 DICARBOXYPHENYLGLYCINE; AMN 082; CARRAGEENAN; DRUG VEHICLE; KAOLIN; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 7; METABOTROPIC RECEPTOR 7 AGONIST; METABOTROPIC RECEPTOR 8; METABOTROPIC RECEPTOR AGONIST; N,N' DIBENZYHYDRYLETHANE 1,2 DIAMINE DIHYDROCHLORIDE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; ELEVATED PLUS MAZE TEST; KNEE ARTHRITIS; MALE; MAZE TEST; MOOD DISORDER; NOCIFENSIVE BEHAVIOR; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SPINAL REFLEX; VOCALIZATION; WITHDRAWAL REFLEX;

AMYGDALA; ANIMALS; ARTHRITIS; BEHAVIOR, ANIMAL; BENZHYDRYL COMPOUNDS; BENZOATES; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; GLYCINE; KAOLIN; MALE; MAZE LEARNING; MICRODIALYSIS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; REFLEX;

EID: 49949087048     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.05.007     Document Type: Article

References (62)

1. Ayala J.E., Niswender C.M., Luo Q., Banko J.L., and Conn P.J. Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated. Neuropharmacology 54 (2008) 804-814
2. Bird G.C., Lash L.L., Han J.S., Zou X., Willis W.D., and Neugebauer V. Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones. J. Physiol. 564 (2005) 907-921
3. Boehnke S.E., and Rasmusson D.D. Time course and effective spread of lidocaine and tetrodotoxin delivered via microdialysis: an electrophysiological study in cerebral cortex. J. Neurosci. Methods 105 (2001) 133-141
4. Borszcz G.S., and Leaton R.N. The effect of amygdala lesions on conditional and unconditional vocalizations in rats. Neurobiol. Learn. Mem. 79 (2003) 212-225
5. Borta A., Wohr M., and Schwarting R.K.W. Rat ultrasonic vocalization in aversively motivated situations and the role of individual differences in anxiety-related behavior. Behav. Brain Res. 166 (2006) 271-280
6. Calvino B., Besson J.M., Boehrer A., and Depaulis A. Ultrasonic vocalization (22-28 kHz) in a model of chronic pain, the arthritic rat: effects of analgesic drugs. NeuroReport 7 (1996) 581-584
7. Cardinal R.N., Parkinson J.A., Hall J., and Everitt B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci. Biobehav. Rev. 26 (2002) 321-352
8. Carrasquillo Y., and Gereau R.W. Activation of the extracellular signal-regulated kinase in the amygdala modulates pain perception. J. Neurosci. 27 (2007) 1543-1551
9. Cryan J.F., Kelly P.H., Neijt H.C., Sansig G., Flor P.J., and van der P.H. Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur. J. Neurosci. 17 (2003) 2409-2417
10. Duvoisin R.M., Zhang C., Pfankuch T.F., O'Connor H., Gayet-Primo J., Quraishi S., and Raber J. Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8. Eur. J. Neurosci. 22 (2005) 425-436
11. Fu Y., and Neugebauer V. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J. Neurosci. 28 (2008) 3861-3876
12. Gallagher R.M., and Verma S. Mood and anxiety disorders in chronic pain. Prog. Pain Res. Management 27 (2004) 139-178
13. Gauriau C., and Bernard J.-F. Pain pathways and parabrachial circuits in the rat. Exp. Physiol. 87 (2002) 251-258
14. Han J.S., Bird G.C., Li W., and Neugebauer V. Computerized analysis of audible and ultrasonic vocalizations of rats as a standardized measure of pain-related behavior. J. Neurosci. Methods 141 (2005) 261-269
15. Han J.S., Bird G.C., and Neugebauer V. Enhanced group III mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala. Neuropharmacology 46 (2004) 918-926
16. Han J.S., Fu Y., Bird G.C., and Neugebauer V. Enhanced group II mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala. Mol. Pain 2 (2006) 18-29
17. Han J.S., Li W., and Neugebauer V. Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior. J. Neurosci. 25 (2005) 10717-10728
18. Han J.S., and Neugebauer V. mGluR1 and mGluR5 antagonists in the amygdala inhibit different components of audible and ultrasonic vocalizations in a model of arthritic pain. Pain 113 (2005) 211-222
19. Hodgson R.A., Guthrie D.H., and Varty G.B. Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: sensitivity to anxiolytic and antidepressant drugs. Pharmacol. Biochem. Behav. 88 (2008) 341-348
20. Hunt S.P., and Mantyh P.W. The molecular dynamics of pain control. Nature 2 (2001) 83-91
21. Ikeda R., Takahashi Y., Inoue K., and Kato F. NMDA receptor-independent synaptic plasticity in the central amygdala in the rat model of neuropathic pain. Pain 127 (2007) 161-172
22. Ji G., Fu Y., Ruppert K.A., and Neugebauer V. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol. Pain 3 (2007) 13-17
23. Ji G., and Neugebauer V. Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala. J. Neurophysiol. 97 (2007) 3893-3904
24. Ji G., and Neugebauer V. Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors. J. Neurophysiol. 99 (2008) 1201-1212
25. Jourdan D., Ardid D., Chapuy E., Eschalier A., and Le B.D. Audible and ultrasonic vocalization elicited by single electrical nociceptive stimuli to the tail in the rat. Pain 63 (1995) 237-249
26. Knutson B., Burgdorf J., and Panksepp J. Ultrasonic vocalizations as indices of affective states in rats. Psychol. Bull. 128 (2002) 961-977
27. Ko S.W., Chatila T., and Zhuo M. Contribution of CaMKIV to injury and fear-induced ultrasonic vocalizations in adult mice. Mol. Pain 1 (2005) 10
28. Kulkarni B., Bentley D.E., Elliott R., Julyan P.J., Boger E., Watson A., Boyle Y., El-Deredy W., and Jones A.K. Arthritic pain is processed in brain areas concerned with emotions and fear. Arthritis Rheum. 56 (2007) 1345-1354
29. Li W., and Neugebauer V. Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain. J. Neurophysiol. 96 (2006) 1803-1815
30. Li X., Gardner E.L., and Xi Z.X. The metabotropic glutamate receptor 7 (mGluR(7)) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats. Neuropharmacology 54 (2008) 542-551
31. Linden A.-M., Johnson B.G., Peters S.C., Shannon H.E., Tian M., Wang Y., Yu J.L., Koster A., Baez M., and Schoepp D.D. Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor. Neuropharmacology 43 (2002) 251-259
32. Marabese I., Rossi F., Palazzo E., de Novellis V., Starowicz K., Cristino L., Vita D., Gatta L., Guida F., Di Marzo V., Rossi F., and Maione S. Periaqueductal gray metabotropic glutamate receptor subtype 7 and 8 mediate opposite effects on amino acid release, rostral ventromedial medulla cell activities, and thermal nociception. J. Neurophysiol. 98 (2007) 43-53
33. Maren S. Synaptic mechanisms of associative memory in the amygdala. Neuron 47 (2005) 783-786
34. Masugi M., Yokoi M., Shigemoto R., Muguruma K., Watanabe Y., Sansig G., van der P.H., and Nakanishi S. Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion. J. Neurosci. 19 (1999) 955-963
35. Mitsukawa K., Mombereau C., Lotscher E., Uzunov D.P., van der P.H., Flor P.J., and Cryan J.F. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology 31 (2006) 1112-1122
36. Mitsukawa K., Yamamoto R., Ofner S., Nozulak J., Pescott O., Lukic S., Stoehr N., Mombereau C., Kuhn R., McAllister K.H., van der Putten H., Cryan J.F., and Flor P.J. A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. PNAS 102 (2005) 18712-18717
37. Neugebauer V. Glutamate receptor ligands. Hand. Exp. Pharmacol. 177 (2007) 217-249
38. Neugebauer V. The amygdala: different pains, different mechanisms. Pain 127 (2007) 1-2
39. Neugebauer V. Group III metabotropic glutamate receptors (mGlu4, mGlu6, mGlu7, and mGlu8). In: Gereau R.W., and Swanson G.T. (Eds). The Glutamate Receptors (2008), Humana Press, Totowa, NJ 489-508
40. Neugebauer V., Han J.S., Adwanikar H., Fu Y., and Ji G. Techniques for assessing knee joint pain in arthritis. Mol. Pain 3 (2007) 8-20
41. Neugebauer V., and Li W. Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain. J. Neurophysiol. 89 (2003) 716-727
42. Neugebauer V., Li W., Bird G.C., Bhave G., and Gereau R.W. Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5. J. Neurosci. 23 (2003) 52-63
43. Neugebauer V., Li W., Bird G.C., and Han J.S. The amygdala and persistent pain. Neuroscientist 10 (2004) 221-234
44. Oliveira A.R., and Barros H.M. Ultrasonic rat vocalizations during the formalin test: a measure of the affective dimension of pain?. Anesth. Analg. 102 (2006) 832-839
45. Palucha A., Tatarczynska E., Branski P., Szewczyk B., Wieronska J.M., Klak K., Chojnacka-Wojcik E., Nowak G., and Pilc A. Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats. Neuropharmacology 46 (2004) 151-159
46. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, New York
47. Pedersen L.H., Scheel-Kruger J., and Blackburn-Munro G. Amygdala GABA-A receptor involvement in mediating sensory-discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury. Pain 127 (2007) 17-26
48. Pelkey K.A., Yuan X., Lavezzari G., Roche K.W., and McBain C.J. mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082. Neuropharmacology 52 (2007) 108-117
49. Phelps E.A., and Ledoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48 (2005) 175-187
50. Rhudy J.L., and Meagher M.W. The role of emotion in pain modulation. Curr. Opin. Psychiatry 14 (2001) 241-245
51. Rhudy J.L., and Meagher M.W. Negative affect: effects on an evaluative measure of human pain. Pain 104 (2003) 617-626
52. Rome H.P., and Rome J.D. Limbically augmented pain syndrome (LAPS): kindling, corticolimbic sensitization, and the convergence of affective and sensory symptoms in chronic pain disorders. Pain Med. 1 (2000) 7-23
53. Schmid S., and Fendt M. Effects of the mGluR8 agonist (S)-3,4-DCPG in the lateral amygdala on acquisition/expression of fear-potentiated startle, synaptic transmission, and plasticity. Neuropharmacology 50 (2006) 154-164
54. Schoepp D.D., Jane D.E., and Monn J.A. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38 (1999) 1431-1476
55. Stachowicz K., Klak K., Pilc A., and Chojnacka-Wojcik E. Lack of the antianxiety-like effect of (S)-3,4-DCPG, an mGlu8 receptor agonist, after central administration in rats. Pharmacol. Rep. 57 (2005) 856-860
56. Stiller C.O., Taylor B.K., Linderoth B., Gustafsson H., Warsame Afrah A., and Brodin E. Microdialysis in pain research. Adv. Drug Deliv. Rev. 55 (2003) 1065-1079
57. Swanson C.J., Bures M., Johnson M.P., Linden A.M., Monn J.A., and Schoepp D.D. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat. Rev. Drug Discov. 4 (2005) 131-144
58. Tanimoto S., Nakagawa T., Yamauchi Y., Minami M., and Satoh M. Differential contributions of the basolateral and central nuclei of the amygdala in the negative affective component of chemical somatic and visceral pains in rats. Eur. J. Neurosci. 18 (2003) 2343-2350
59. Thomas N.K., Wright R.A., Howson P.A., Kingston A.E., Schoepp D.D., and Jane D.E. (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology 40 (2001) 311-318
60. Varney M.A., and Gereau R.W. Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics. Current Drug Targets 1 (2002) 215-225
61. Yu Y.C., Koo S.T., Kim C.H., Lyu Y., Grady J.J., and Chung J.M. Two variables that can be used as pain indices in experimental animal models of arthritis. J. Neurosci. Methods 115 (2002) 107-113
62. Zald D.H. The human amygdala and the emotional evaluation of sensory stimuli. Brain Res. Rev. 41 (2003) 88-123